F I L E D
United States Court of Appeals
Tenth Circuit
UNITED STATES COURT OF APPEALS
June 29, 2005
TENTH CIRCUIT
PATRICK FISHER
Clerk
HORACE BARNES,
Plaintiff-Appellant, No. 04-3445
v. District of Kansas
UNITED STATES OF AMERICA, (D.C. No. 01-CV-3202-KHV)
Defendant-Appellee.
ORDER AND JUDGMENT *
Before SEYMOUR, HARTZ, and McCONNELL, Circuit Judges.
Plaintiff-Appellant Horace Barnes, a federal prisoner proceeding pro se,
appeals the district court’s grant of the government’s motion to dismiss and for
summary judgment. Exercising jurisdiction under 28 U.S.C. § 1291, we AFFIRM
the district court’s order in part and VACATE in part. Mr. Barnes also moves to
proceed in forma pauperis pursuant to 28 U.S.C. § 1915. That motion is
*
After examining the briefs and appellate record, this panel has
determined unanimously that oral argument would not materially assist in the
determination of this appeal. See Fed. R. App. P. 34(a)(2); 10th Cir. R. 34.1(G).
This order and judgment is not binding precedent, except under the doctrines of
law of the case, res judicata, and collateral estoppel. The court generally disfavors
the citation of orders and judgments; nevertheless, an order and judgment may be
cited under the terms and conditions of 10th Cir. R. 36.3.
GRANTED. Mr. Barnes’s motion for a temporary restraining order is DENIED.
I.
Mr. Barnes is an inmate at the United States Penitentiary in Leavenworth,
Kansas (“USP Leavenworth”). Between August 15, 1997 and May 21, 1998,
medical staff at USP Leavenworth treated Mr. Barnes approximately fifteen times
for a rash and skin irritation on his penis. On December 28, 1998, Mr. Barnes
complained of skin irritation on his inner thigh, scrotum, and penis. H. Al-
Ruballe, a physician’s assistant, diagnosed him with jock itch and prescribed
Tolnaftate. On January 27, 1999, Mr. Barnes complained of a penis infection.
Mr. Al-Ruballe diagnosed him with condylomata acuminata (genital warts),
prescribed Podofilox, and treated him from an unlabelled bottle. When Mr.
Barnes returned the next day with complaints of swelling and soreness in the
affected area, Mr. Al-Ruballe discontinued the Podofilox. Mr. Al-Ruballe and
Dr. Phillip Hill, the clinical director at USP Leavenworth, prescribed
Sulfameth/Trimeth and Clotrimazole. The swelling and soreness “quickly
resolved itself because [Mr. Barnes] was never again given a Podo[f]ilox
treatment from an unlabelled bottle.” Plaintiff’s Objection to Motion for
Summary Judgment, R. Doc. 27, at 28.
On May 22, 2000, Mr. Barnes filed an administrative tort claim with the
Bureau of Prisons alleging that Mr. Al-Ruballe and Dr. Hill treated him
2
improperly on January 27 and 28, 1999. He sought $100,000 in damages. On
October 19, 2000, the BOP denied Mr. Barnes’s claim and informed him that he
had six months to file suit in federal court. On April 19, 2001, Mr. Barnes filed a
pro se complaint under the Federal Tort Claims Act, 28 U.S.C. § 2671, and Bivens
v. Six Unknown Named Agents of the Federal Bureau of Narcotics, 403 U.S. 388
(1971), alleging negligent treatment by prison medical staff on several occasions
from 1997 to 1999 and seeking $4 million in compensatory damages and $4
million in punitive damages. The district court dismissed the Bivens claim
because Mr. Barnes did not allege a violation of his constitutional rights, and it
substituted the United States as the sole defendant as required by the FTCA.
On September 24, 2002, the government filed a motion to dismiss or,
alternatively, for summary judgment on the grounds that (1) the FTCA claim was
time-barred; (2) except for the allegations of negligent medical care between
January 26 and January 28, 1999, Mr. Barnes failed to exhaust his administrative
remedies; (3) relief should be limited to the amount requested in the
administrative claim; and (4) the evidence did not create a genuine issue of
material fact on the FTCA claim. Mr. Barnes filed a motion for continuance of
summary judgment, pursuant to Rule 56(f), seeking time to obtain affidavits and
discovery to oppose summary judgment. After the government objected to the
motion for failure to comply with Rule 56(f), Mr. Barnes filed a second Rule
3
56(f) motion, which sought an order that a photographer be allowed to enter USP
Leavenworth to photograph his penis. The government objected to the second
motion for failure to comply with Rule 56(f). On October 28, 2002, Mr. Barnes
filed his response to the government’s motion along with his own affidavit and
exhibits. Mr. Barnes then filed a number of motions seeking to supplement his
response to the government’s motion for summary judgment, a motion for
appointment of counsel, a motion for leave to serve interrogatories, a motion for
physical examination, and a motion for preliminary injunction against BOP staff,
who allegedly interfered with his efforts to pursue his claims. On September 30,
2003, the district court granted Mr. Barnes’s motion to supplement, but it denied
the motions for continuance, discovery, physical examination, appointment of
counsel, and preliminary injunction. Mr. Barnes filed a renewed motion for a
restraining order, which the district court summarily denied along with two
pending motions to amend and supplement on July 9, 2004. On July 16, 2004,
Mr. Barnes filed a motion for clarification of the court’s order of July 9 denying
his request for a temporary restraining order.
On September 27, 2004, the district court granted the government’s motion
to dismiss in part, holding that Mr. Barnes’s complaint was not time-barred, but
that he failed to exhaust his administrative remedies for all but two claims: (1)
that Mr. Al-Ruballe negligently treated him with medicine from an unlabeled
4
bottle on January 27, 1999, and (2) that Mr. Al-Ruballe and Dr. Hill negligently
prescribed Clotrimazole on January 28, 1999. The court granted the
government’s motion for summary judgment on the two exhausted claims. The
court also denied Mr. Barnes’s motion for clarification, explaining that it was a
summary order, and to the extent he sought reconsideration, his request was
denied because he failed to comply with local rules. Mr. Barnes filed a motion to
reconsider, which the court denied.
We review the district court’s dismissal for failure to exhaust
administrative remedies de novo. Jernigan v. Stuchell, 304 F.3d 1030, 1032 (10th
Cir. 2002). We review the district court’s grant of summary judgment de novo,
viewing all the facts in the light most favorable to the plaintiff. See Simms v.
Okla. ex rel. Dept. of Mental Health & Substance Abuse Servs., 165 F.3d 1321,
1326 (10th Cir. 1999). We review the denial of a motion to reconsider for abuse
of discretion. Royal Maccabees Life Ins. Co. v. Choren, 393 F.3d 1175, 1183
(10th Cir. 2005).
II.
A. Dismissal for Failure to Exhaust Administrative Remedies
On appeal, Mr. Barnes argues that the district court erred in dismissing all
but two of his claims for failure to exhaust. The FTCA waives the federal
government’s sovereign immunity to suits for money damages arising out of the
5
negligence of government agents. See 28 U.S.C. 1346(b); FDIC v. Meyer, 510
U.S. 471, 475 (1994). As a condition of this waiver, however, the FTCA requires
a claimant to exhaust administrative remedies before bringing a claim against the
United States in federal court. 28 U.S.C. § 2675(a). To satisfy the exhaustion
requirement, the claimant must file an administrative claim including “(1) a
written statement sufficiently describing the injury to enable the agency to begin
its own investigation, and (2) a sum certain damages claim.” Cizek v. United
States, 953 F.2d 1232, 1233 (10th Cir. 1992).
Mr. Barnes complied with the FTCA by filing an administrative claim with
the BOP; however, his administrative complaint was limited to the following
factual allegations:
On January 26, 1999, I spoke to H. Al-Ruballe PA, about this
problem I was having with my penis. Ruballe was full[y] aware of
this . . . problem [in] 1997. Ruballe then treated the problem with
(PODO[F]ILOX). The next day on January 27, 1999, I brought to his
attention that my penis was swelling up around the head of my penis
and the medication was beginning to burn me under my scrotum. On
January 27, 1999, I wrote [an] inmate request form to Phillip Keith
Hill, M.D. Chief Medical Officer, and Dr. Hill, refu[s]ed to
acknowledg[e] my request form on January 28, 1999.
. . . Ruballe PA, ordered and recommended, Sulfameth 800/160 and
(CLORIMAZOLE CREAM %). Karen Todd AHSA, used false
information in inmate grievances BP-8, by mis-representation and
conspiracy to cover-up the truth for H. Al-Ruballe, Staff Physician
Assistant.
Doc. 20, Exh. A-2. The FTCA’s exhaustion requirement is intended to provide
notice to the agency so that it can investigate the claim. See Estate of Trentadue
6
ex rel. Aguilar v. United States, 397 F.3d 840, 852-53 (10th Cir. 2005). Mr.
Barnes’s administrative complaint provided notice of his complaint only insofar
as it arose from the events of January 26 to January 28, 1999. With respect to
claims arising from treatment on other dates, Mr. Barnes failed to exhaust his
administrative remedies, and the district court properly granted the government’s
motion to dismiss. To the extent Mr. Barnes’s suit survives, his damage claim is
limited to $100,000, the sum certain claimed in his administrative complaint.
B. Summary Judgment
The district court granted the government’s motion for summary judgment
on Mr. Barnes’s two remaining malpractice claims. The FTCA provides for
liability “under circumstances where the United States, if a private person, would
be liable to the claimant in accordance with the law of the place where the act or
omission occurred.” 28 U.S.C. § 1346(b)(1). Because the relevant conduct
occurred in Kansas, the claim is governed by Kansas law. To state a prima facie
case of medical malpractice in Kansas, a plaintiff must show that the defendant
owed him a duty, that the defendant breached the duty, and that the defendant’s
breach of the duty caused the plaintiff’s injury. See, e.g., Sharples v. Roberts,
816 P.2d 390, 397 (Kan. 1991).
1. The Unlabeled Bottle
Mr. Barnes alleges that on January 27, 1999, Mr. Al-Ruballe gave him
7
medicine from an unlabeled bottle. Mr. Al-Ruballe informed Mr. Barnes that the
bottle contained Podofilox. After he received the medicine from the unlabeled
bottle, Mr. Barnes experienced swelling and pain. Mr. Barnes alleges that he had
received Podofilox in the past without any adverse reaction; therefore, something
other than Podofilox must have been in the unmarked bottle.
The court concluded that if Mr. Barnes verified his factual allegations, a
reasonable jury might conclude that Mr. Al-Ruballe breached the standard of care
by giving him medicine from an unlabeled bottle. The court also concluded that,
assuming Mr. Barnes could submit a verified statement, a reasonable jury could
conclude that he was injured by taking the substance in the unlabeled bottle. The
district court thus reduced the claim to one key fact question: What was in the
unlabeled bottle? The district court held that the government was entitled to
summary judgment because Mr. Barnes “has not shown what was in the bottle or
that it was something other than Podofilox—what Al-Ruballe intended to use and
what plaintiff had received in the past with no adverse reaction.” Id. at 15-16.
Accordingly, the court concluded that even if Mr. Barnes submitted a verified
complaint, “[n]o reasonable jury could find that plaintiff was injured because the
bottle was not labeled.” Id at 16.
The district court’s legal conclusion was erroneous. It is true that Mr.
Barnes did not show exactly what was in the bottle. He alleged, however, that
8
after he was treated with the medicine in the unlabeled bottle, he suffered an
adverse reaction. He also alleges that he had used Podofilox in the past with no
adverse reaction. Submitted in proper form, his allegation that he suffered an
adverse reaction to the medicine in the unlabeled bottle raises a genuine question
of material fact, namely, whether the bottle really contained Podofilox. If the
bottle contained something other than Podofilox, the lack of a label contributed to
the alleged injury because it prevented Mr. Al-Ruballe from realizing that he was
giving Mr. Barnes the wrong medicine. A reasonable jury could therefore
conclude that Mr. Al-Ruballe’s negligence injured Mr. Barnes.
Because the district court did not rely on Mr. Barnes’s failure to submit
verified statements, we hesitate to affirm on this alternative ground. As the
district court noted, verification would have been sufficient to remedy the defects
in Mr. Barnes’s summary judgment proof. See Hall v. Bellmon, 935 F.2d 1106,
1111 (10th Cir. 1991) (“The plaintiff’s complaint may also be treated as an
affidavit if it alleges facts based on the plaintiff’s personal knowledge and has
been sworn under penalty of perjury.”). We have cautioned that “district courts
must take care to insure that pro se litigants are provided with proper notice
regarding the complex procedural issues involved in summary judgment
proceedings.” Id.
On the other hand, it appears that Mr. Barnes was on notice that his proof
9
was defective. The district court’s order granting summary judgment noted that
his unsworn statement was insufficient to survive summary judgment. Mr. Barnes
did not submit a sworn statement with his motion for reconsideration.
Nevertheless, the district court’s order suggests an inclination to overlook
formal defects for purposes of summary judgment. In considering Mr. Barnes’s
letters from Bayer and the FDA, the court stated that “[a]lthough the statements
are not properly authenticated, plaintiff could likely obtain such authentication
before trial.” Mem. & Order, R. Doc. 81, at 16. The court’s forbearance seems
appropriate in light of Mr. Barnes’s tenuous grasp of summary judgment
procedure and burdens of proof. See Aplt. Br. at 11A (“This Court’s standard of
review for cases dismissed by way of summary judgment pursuant to Rule 12(b) is
de novo, for failure to state a claim, while in this case . . . the court below
dismissed because Appellant did not ‘prove’ his case in the pleadings.”); see also
Mem. & Order (Motion to Reconsider), R. Doc. 85, at 3.
The district court’s erroneous legal conclusion was based on the heuristic
assumption that Mr. Barnes could produce an admissible statement of his factual
allegations. Whether the district court meant to excuse Mr. Barnes’s failure to do
so is not clear from the order granting summary judgment. The decision to permit
Mr. Barnes to remedy the defects in his evidence before trial is within the
discretion of the district court. We therefore vacate the district court’s order in
10
part and remand for consideration of this issue.
2. Prescription of Clotrimazole
Mr. Barnes also claims that on January 28, 1999, BOP medical staff
negligently prescribed Clotrimazole to treat condylomata (genital warts). Mr.
Barnes presented letters from Bayer Corporation and the Food and Drug
Administration demonstrating that Clotrimazole is not indicated for the treatment
of condylomata. The letters were not authenticated, but the district court stated
that Mr. Barnes could likely authenticate them before trial; therefore a reasonable
jury could find that Mr. Al-Ruballe and Dr. Hill breached the standard of care by
prescribing Clotrimazole. Id. The court granted summary judgment, however,
because “[a]bsent expert testimony, plaintiff cannot show that the prescription of
Clotrimazole on January 28, 1999 caused any of his injuries.” Id.
On appeal, Mr. Barnes attributes his failure of proof to BOP staff’s
interference with his legal mail, which allegedly prevented him from
communicating with potential outside counsel and experts. He alleges that the
prison mail room refused to return documents that he sent to certain outside
parties and that this interference discouraged outside assistance. In support of
this argument, he submitted two letters from Karen Russo of The Wirken Law
Group. The first, dated May 20, 2003, indicates that Ms. Russo returned files to
Mr. Barnes and received a return receipt, but the files were sent back without
11
explanation. In the second letter, dated June 5, 2003, Ms. Russo referred to the
first letter and again informed Mr. Barnes that she had tried to return his files.
She stated that Mr. Barnes had “failed to provide us with either a correct address
for you; or made the necessary arrangements at the prison to accept your legal
documents.” Renewed Application for Restraining Order, Rec. Doc. 68, Exh. 2,
Doc. C. He also submitted two Inmate Personal Property Records, dated May 23,
2003 and June 17, 2003, which show that he possessed 32 inches and 10 inches of
legal material, respectively. Aplt. Br. Exh. 1.
Mr. Barnes does not provide any details of his efforts to secure expert
testimony, nor does he explain how the prison’s alleged interference with his mail
frustrated these efforts. For example, he does not provide any specific
information about the legal documents, mentioned in Ms. Russo’s letters, that
prison officials returned to the Wirken Law Group. The March 11, 1999 letter
from Bayer Corporation and the November 1, 2001 letter from the FDA indicate
that he had the ability to communicate with outside parties. Because Mr. Barnes
failed to present competent evidence of causation, the district court did not err in
granting summary judgment on this claim. Because he has not indicated how the
prison’s alleged interference with his mail prevented him from securing an expert
witness, the court did not abuse its discretion in denying his motion for
reconsideration.
12
III.
On June 6, 2005, Mr. Barnes filed a motion for a temporary restraining
order against the BOP to prevent his transfer to a prison other than USP
Leavenworth. Mr. Barnes argues that transfer to another prison would violate his
right to pursue his claims in violation of due process, the First Amendment, and
Appellate Rule 23(a). We see no basis for a temporary restraining order, and we
DENY the motion.
The Federal Rules of Appellate Procedure do not provide Mr. Barnes with a
right to relief. Rule 23(a) restricts a custodian’s ability to transfer a prisoner
during the appeal of a habeas corpus petition. Fed. R. App. P. 23(a). Mr. Barnes
has not filed a habeas petition; he filed a complaint under the FTCA. Rule 23(a)
therefore does not restrict the BOP’s ability to transfer him during his appeal.
Nor can Mr. Barnes establish a right to a temporary restraining order on
other grounds. Among other things, a temporary restraining order requires that “it
clearly appear[] from specific facts shown by affidavit or by the verified
complaint that immediate and irreparable injury . . . will result to the applicant.”
Fed. R. Civ. P. 65(b). Mr. Barnes maintains that transfer out of USP
Leavenworth will result in the dismissal of his suit for lack of jurisdiction.
Application for TRO at 2 (“[T]ransfer out of the jurisdiction of this Court or the
court below will violate Appellant’s right to bring suit . . . within the area and
13
district where the mal-practice took place” and “cause the dismissal of the lawsuit
as Appellant would not be within the jurisdiction.”). This fear is unfounded. By
filing his complaint and his notice of appeal, Mr. Barnes has properly invoked the
jurisdiction of the district court and of this Court, respectively. His absence from
the State of Kansas or any other state in the Tenth Circuit does not divest this
Court of jurisdiction. Because Mr. Barnes has not provided specific facts
showing an imminent and irreparable injury, we deny his motion for a temporary
restraining order.
IV.
For the reasons stated above, we AFFIRM the district court’s grant of
summary judgment in part, VACATE in part, and REMAND for proceedings
consistent with this order. The motion for a temporary restraining order is
DENIED. Mr. Barnes’s motion to proceed in forma pauperis is GRANTED, but
we remind Mr. Barnes that he must continue to make partial payments of his
filing fee.
Entered for the Court,
Michael W. McConnell
Circuit Judge
14